skip to content
  1. Home
  2. >
  3. Questions
  4. >
  5. GUD: It was mentioned in the 31 March 2025 end quarterly report that the company is buying out some asset back from Endo for 100-mil plus inventory. [Knight Therapeutics Inc.]

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: It was mentioned in the 31 March 2025 end quarterly report that the company is buying out some asset back from Endo for 100-mil plus inventory. Do you think that the asset which company purchased will do well as Endo acquired it and kept it. Now they are disposing it. Is company found them not valuable enough to generate good return? If that is the reason then why GUD bought it? Will GUD manage to generate good return out of it?
Thanks
Piyush
Asked by Piyush on June 05, 2025
5i Research Answer:
GUD is buying Paladin Pharma from Endo. Paladin was the company that the founders of GUD built...
Sign up today for a free 14-day trial and continue your reading!

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; unbiased stocks research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!

Let us help YOU reach your financial goals today!

Start your FREE trial today and enjoy all the benefits of a 5i Membership including:

  • Access to a team of experts ready to answer your investments question 
  • Instant access to over 100,000 archived questions
  • A community of like-minded investors
  • Peace of mind knowing that 5i Research has only YOUR best interests in mind